These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog. Bai SA; Walle UK; Walle T J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163 [TBL] [Abstract][Full Text] [Related]
4. No stereoselective first-pass hepatic extraction of propranolol. Jackman GP; McLean AJ; Jennings GL; Bobik A Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593 [TBL] [Abstract][Full Text] [Related]
5. Variable first-pass elimination of propranolol following single and multiple oral doses in hypertensive patients. Wargin WA; Sawchuk RJ; McBride JW; McCoy HG; Rylander ML Eur J Drug Metab Pharmacokinet; 1982; 7(3):183-9. PubMed ID: 7173272 [TBL] [Abstract][Full Text] [Related]
7. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man. Evans GH; Shand DG Clin Pharmacol Ther; 1973; 14(4):487-93. PubMed ID: 4723255 [No Abstract] [Full Text] [Related]
8. Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man. Evans GH; Shand DG Clin Pharmacol Ther; 1973; 14(4):494-500. PubMed ID: 4723256 [No Abstract] [Full Text] [Related]
10. Kinetics and cardiac effects of propranolol in humans. Ochs HR; Grube E; Greenblatt DJ; Knüchel M; Bodem G Klin Wochenschr; 1982 May; 60(10):521-5. PubMed ID: 7098380 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of propranolol: a review. Shand DG Postgrad Med J; 1976; 52 Suppl 4():22-25. PubMed ID: 787953 [TBL] [Abstract][Full Text] [Related]
12. The effect of ageing on the hepatic clearance of propranolol. Castleden CM; George CF Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742 [TBL] [Abstract][Full Text] [Related]
13. The use of drug concentration measurements in studies of the therapeutic response to propranolol. Chidsey C; Pine M; Favrot L; Smith S; Leonetti G; Morselli P; Zanchetti A Postgrad Med J; 1976; 52 Suppl 4():26-32. PubMed ID: 967771 [TBL] [Abstract][Full Text] [Related]
14. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing. Wells PG; Feely J; Wilkinson GR; Wood AJ Clin Pharmacol Ther; 1983 May; 33(5):603-8. PubMed ID: 6839632 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability of propranolol in the dog. Tse FL; Sanders TM; Reo JP Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706 [TBL] [Abstract][Full Text] [Related]
17. The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat. Evans GH; Nies AS; Shand DG J Pharmacol Exp Ther; 1973 Jul; 186(1):114-22. PubMed ID: 4198771 [No Abstract] [Full Text] [Related]
18. 4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol. Walle T; Conradi EC; Walle UK; Fagan TC; Gaffney TE Clin Pharmacol Ther; 1980 Jan; 27(1):22-31. PubMed ID: 7351114 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the pharmacokinetics of propranolol in obese and normal volunteers. Bowman SL; Hudson SA; Simpson G; Munro JF; Clements JA Br J Clin Pharmacol; 1986 May; 21(5):529-32. PubMed ID: 3718810 [TBL] [Abstract][Full Text] [Related]
20. Effect of age on the hepatic clearance of propranolol in rats. Iwamoto K; Watanabe J; Araki K; Deguchi N; Sugiyama H J Pharm Pharmacol; 1985 Jul; 37(7):466-70. PubMed ID: 2863348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]